Table 2.
Tumor indicators at the time of admission
|
Parameter
|
Patient’s value
|
Reference value
|
| Carcinoembryonic antigen (ng/mL) | 1.36 | 0–5.0 |
| Alpha-fetoprotein (ng/mL) | 1.71 | < 9.01 |
| CA-199 (U/mL) | 3.40 | 0–25 |
| β-human chorionic gonadotropin (mIU/mL) | 0.24 | 0–35 |
| CA-125 (U/mL) | 15.17 | 0–5 |
| CA-15-3 (U/mL) | 3.10 | 0–14 |
| CA-50 (U/mL) | 3.91 | < 25 |
| CA-72-4 (U/mL) | 4.02 | 0–10 |
| CA-24-2 (U/mL) | 4.27 | < 25 |
| Squamous cell carcinoma-associated antigen (ng/mL) | 0.78 | 0–1.5 |
| Cytokeratin 19 fragment (ng/mL) | 1.59 | < 3.3 |
| Neuron specific enolase (ng/mL) | 9.93 | 0–20 |
Alpha-fetoprotein (ng/ml) < 9.0 in males and non-pregnant females.